Wednesday, October 28, 2020
Want create site? Find Free WordPress Themes and plugins.

Plea Filed In Patiala House Court Seeking Directions To Register FIR Against Baba Ramdev And Patanjali For Allegedly Making Claims To Cure COVID 19

Want create site? Find Free WordPress Themes and plugins.

A plea has been filed in the Patiala House Court seeking directions register an FIR against Baba Ramdev and Patanjali under the Indian Penal Code, Drugs and Magic Remedies (Objectionable Advertisements) Act, and Drugs and Cosmetics Act for allegedly making claims to cure COVID 19.

The complainant Tushar Anand, a practicing Advocate has submitted that at a press conference held on June 23, Baba Ramdev and Acharya Balkrishna had made claims that they have developed a medicine namely “Coronil” which fully cures a patient suffering from COVID 19.

The complainant has submitted that Baba Ramdev along with the other associated with Patanjali Ayurveda have acted jointly in a pre planned conspiracy to take undue advantage of their special status in the society by making false claims of having found a cure for COVID 19.

The complainant has further informed the Court that Patanjali was granted permission to make an immunity booster and not a medicine having cure of COVID 19.

Further, Patanjali has violated the AYUSH ministry’s directives dated April 24 according to which it is mandatory for an institution “to apprise the Ministry of AYUSH , Government of India about the research and developments.”

The complainant has stated that Baba Ramdev and others have violated the provisions of Section 33(E) (Misbranded Drugs) read with section 33(I) (Penalty for misbranded drugs) of the Drugs and Cosmetics Act 1940 for the offence of “Misbranded Drugs”.

Further it has been alleged that the accused persons have also committed offence under Section 4 (Prohibition of misleading advertisements relating to drugs) and section 7 (penalty up to 6 months) of the Drugs and magic Remedies (Objectionable Advertisements) Act, 1954.

Moreover the accused persons have also violated Rule 170 of the Drugs and Cosmetics Rules, 2018 according to which diagnosis, cure, mitigation, treatments, or prevention of any disease, disorder, syndrome or condition cannot be advertised.

-India Legal Bureau

Did you find apk for android? You can find new Free Android Games and apps.

News Update

Supreme Court seeks opinion of high courts on Draft Rules for Criminal Practice

New Delhi (ILNS): The Supreme Court of India today sought response from all the High Courts on ‘Draft Rules Of Criminal Practice’ in a suo moto matter with regards to the inadequacies and inefficiencies in the criminal trial system.

Delhi court set aside order summoning Haryana MLA, businessman in suicide case

Delhi’s Rohini Court has set aside an order summoning Haryana MLA and businessman Gopal Goyal Kanda and his former associate Aruna Chadha in the Abetment to suicide case of flight attendant Geetika Sharma’s mother.

Case of neglected typist: Jharkhand High Court rules for equal pay when work delivered is equal

The Jharkhand High Court has said that equal pay in lieu of equal work is not a fundamental right, but looking at the Directive Principles of State Policy it appears to be a fundamental right. For this reason, the demand for equal pay in lieu of equal work cannot be considered unnecessary.

Centre notifies Jammu and Kashmir, Ladakh land laws, removes restriction on purchase of land

In the latest development, the MHA has notified land laws paving the way for Indian citizens to buy land in Jammu and Kashmir and Ladakh. The ministry in a statement stated that the order will be called Union Territory of Jammu and Kashmir Reorganization (Adaptation of Central Laws) Third Order, 2020.

Supreme Court rejects non-specific plea on farm acts

The Supreme Court has dismissed a plea seeking the implementation of the three farm acts and framing strict guidelines against the agitation and procession by political parties.
Did you find apk for android? You can find new Free Android Games and apps.